Human megakaryocytes and platelets contain the estrogen receptor β and androgen receptor (AR): testosterone regulates AR expression
Authors:
Open Access
- 1 April 2000
- journal article
- Published by American Society of Hematology in Blood
- Vol. 95 (7) , 2289-2296
Abstract
Gender differences in vascular thromboses are well known, and there is evidence that platelets may be involved in these differences and that sex hormones affect platelet function. We characterized the expression of the estrogen receptor (ER ), estrogen receptor β (ER β), progesterone receptor (PR), and androgen receptor (AR) in the megakaryocyte lineage. Megakaryocytes generated ex vivo from normal human CD34+ stem cells contained RNA for ER β and AR, which increased with cell differentiation. Platelets and human erythroleukemia (HEL) cells also contained ER β and AR transcripts. No ER or PR messenger RNA or protein was detected in the megakaryocyte lineage. Immunofluorescence microscopy showed that ER β protein was present in glycoprotein (GP) IIb+ megakaryocytes and the HEL megakaryocytic cell line in a predominantly cytoplasmic location. AR showed a cytoplasmic and nuclear distribution in GPIIb+ and GPIIb− cells derived from CD34+ cells and in HEL cells. Western immunoblotting confirmed the presence of ER β and AR in platelets. Megakaryocyte and HEL AR expression was up-regulated by 1, 5, and 10 nmol/L testosterone, but down-regulated by 100 nmol/L testosterone. These findings indicate a regulated ability of megakaryocytes to respond to testosterone and suggest a potential mechanism through which sex hormones may mediate gender differences in platelet function and thrombotic diseases.Keywords
This publication has 47 references indexed in Scilit:
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998
- Recent Epidemiological Studies of the Association Between Hormone Replacement Therapy and Venous ThromboembolismDrug Safety, 1998
- Risk of venous thromboembolism in users of hormone replacement therapyThe Lancet, 1996
- ESTROGENS, MENOPAUSE, AND CORONARY ARTERY DISEASE*Cardiology Clinics, 1996
- Further Evidence of the Presence of Constitutive and Inducible Nitric Oxide Synthase Isoforms in Human PlateletsJournal of Cardiovascular Pharmacology, 1996
- Testosterone Increases Human Platelet Thromboxane A2Receptor Density and Aggregation ResponsesCirculation, 1995
- The Estrogen Receptor Is Present in Human MegakaryocytesAnnals of the New York Academy of Sciences, 1994
- Effects of Postmenopausal Estrogen Replacement on the Concentrations and Metabolism of Plasma LipoproteinsNew England Journal of Medicine, 1991
- Menopause and the Risk of Coronary Heart Disease in WomenNew England Journal of Medicine, 1987
- Superoxide production and reducing activity in human platelets.Journal of Clinical Investigation, 1977